Tag Archives: CDMO

Empowering Radiopharmaceutical Innovation: A Global Supply Pact Between Eckert & Ziegler and AtomVie

(IN BRIEF) Eckert & Ziegler SE and AtomVie Global Radiopharma Inc. have announced a significant global supply agreement aimed at supporting AtomVie’s radiopharmaceutical manufacturing efforts. Under this agreement, Eckert & Ziegler will provide its high-grade non-carrier added Lutetium-177 chloride (Theralugand®) … Read the full press release

EQT BPEA V Fund to exit from Bushu Pharmaceuticals, one of the leading CDMOs in Japan

(PRESS RELEASE) STOCKHOLM, 20-Dec-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced that its BPEA V Fund will divest Bushu Pharmaceuticals, a leading CMO in Japan that produces high-quality pharmaceutical and medical devices, by selling it to … Read the full press release

EQT BPEA V Fund se retire de Bushu Pharmaceuticals, l’un des principaux CDMO au Japon

(COMMUNIQUÉ DE PRESSE) STOCKHOLM, 20-Dec-2022 — /EuropaWire/ — EQT, une organisation d’investissement mondiale axée sur les objectifs, a annoncé que son fonds BPEA V cèdera Bushu Pharmaceuticals, un chef de file du marketing au Japon qui produit des des dispositifs … Read the full press release